Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Journal of Internal Medicine|September 23, 2025
Characterizing VEXAS syndrome in women: Findings from an international multicenter studyRim Bourguiba, Valentin Lacombe, David Beck, et al.Haematologica|April 10, 2025
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS RegistryBente Houtman, Adele Taylor, Corine Van Marrewijk, et al.British Journal of Haematology|February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategiesAleksandar Savic, Adele Taylor, Pierre Fenaux, et al.American Journal of Hematology|October 18, 2021
Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatmentArthur Mageau, Louis Terriou, Mikael Ebbo, et al.Kidney International Reports|December 18, 2023
Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe DiseaseMarie-Camille Lafargue, Mickaël Bobot, Helmut G Rennke, et al.British Journal of Haematology|January 24, 2024
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registryGuillaume Moulis, Manuela Rueter, Aymeric Duvivier, et al.Leukemia|April 4, 2024
Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasmsCharles Dussiau, Thibault Comont, Camille Knosp, et al.Blood Advances|January 28, 2025
Efficacy and safety of dapsone in adult primary immune thrombocytopeniaMarion Larue, Guillaume Moulis, Manuela Rueter, et al.American Journal of Hematology|January 8, 2026
Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN-FranceFrançois Therme, Jean Francois Viallard, Manuela Rueter, et al.British Journal of Haematology|June 21, 2021
Eltrombopag for myelodysplastic syndromes or chronic myelomonocytic leukaemia with no excess blasts and thrombocytopenia: a French multicentre retrospective real-life studyThibault Comont, Mathieu Meunier, Amina Cherait, et al.Pageof 5